Portfolio
Corner Office
Culture
Premium
Opinion
Events
Video
Innovation
Subscribe
Sign In
Register
Menu
Subscribe
Sign In
Register
Portfolio
Corner Office
Culture
Premium
Opinion
Events
Video
Innovation
Subscribe
Sign In
Register
Search Query
Submit Search
Show Search
Steve Taub
Latest articles
Hedge Funds
Quantedge Leads Rebound in CTAs and Trend Following Hedge Funds
Steve Taub
October 10, 2024
Hedge Funds
Tech-Focused Cadian Suffers Another Loss, Adding to Its Woes This Year
Steve Taub
October 9, 2024
Hedge Funds
As Demand Grows for Evergreen Funds, Credit Manager Canyon Launches Its Own Version
Steve Taub
October 8, 2024
Hedge Funds
A Strong September Doesn’t Help Third Point’s Lagging Performance This Year
Steve Taub
October 7, 2024
Hedge Funds
Hedge Funds Slow Down on Life Science Deals
Steve Taub
October 3, 2024
Hedge Funds
Hedge Fund Faves Lagged the S&P 500 in the Third Quarter
Steve Taub
October 2, 2024
Hedge Funds
David Einhorn’s Hedge Fund Continues to Lag the Market
Steve Taub
October 1, 2024
Hedge Funds
Hedgies Still Shun Private Tech Investments
Steve Taub
September 30, 2024
Hedge Funds
A New Name Cracks Tiger Cub Chris Hansen’s Top Stocks
Steve Taub
September 26, 2024
Hedge Funds
Hedge Funds Miss Out on Gains from New Top Stock Vistra
Steve Taub
September 25, 2024
Hedge Funds
A Small Hedge Fund That Has Doubled Investors’ Money in Four Years
Steve Taub
September 24, 2024
Hedge Funds
The IPO Market Is Back — For One Sector
Steve Taub
September 23, 2024
Hedge Funds
Cliff Sosin’s Hedge Fund Can (Mostly) Thank This One Stock
Steve Taub
September 19, 2024
Hedge Funds
Tiger Cub Maverick Flirts With a Major Milestone
Steve Taub
September 18, 2024
Hedge Funds
Discovery’s Robert Citrone Turns 25 as One of the Top Hedge Funds
Steve Taub
September 16, 2024
Hedge Funds
Biopharma Hedge Funds Extend Gains
Steve Taub
September 12, 2024
Hedge Funds
Hedge Fund Mulvaney Leads CTA Setback
Steve Taub
September 11, 2024
Hedge Funds
Hedge Funds Stand to Gain as Biopharma IPOs Heat Up
Steve Taub
September 10, 2024